文献速递肝胆胰外科胃肠外科围术期管理与 ERAS

腹腔镜微波消融与切除治疗小单发结直肠癌肝转移的多中心长期结果分析

Laparoscopic Microwave Ablation vs Resection for Small Solitary Colorectal Liver Metastases: Multicenter Analysis of Long-Term Results.
PubMed 文献 · J Am Coll Surg · 2026-01-15

这项多中心回顾性研究比较了腹腔镜微波消融(MWA)与肝切除(LR)治疗小于3cm单发结直肠癌肝转移(CRLM)的肿瘤学结局。中位随访76个月后,两组总生存(5年51.5% vs 56.7%,p=0.6404)和无病生存(5年30.5% vs 36.2%,p=0.1042)均无显著差异,LR组住院时间更长。结论支持在合适患者中MWA相对于LR的非劣效性。

要点

  • 对于小于3cm单发CRLM,腹腔镜MWA与LR的5年总生存和无病生存无显著差异。
  • MWA组患者年龄更大、合并症指数更高、肿瘤位于后上段比例更高。
  • LR组住院时间显著长于MWA组(4天 vs 1天,p<0.0001)。

核心结论

  • 对于小于3cm的单发结直肠癌肝转移,腹腔镜微波消融与肝切除在无病生存和总生存方面具有可比性。
  • 研究结果支持在合适患者中,消融相对于切除在手术治疗小单发CRLM方面具有非劣效性。

研究设计与样本

  • 回顾性多中心研究,纳入3个中心25年间接受肝切除或微波消融治疗的单发小于3cm结直肠癌肝转移患者。
  • 微波消融组158例,肝切除组218例,均为一线局部肝脏治疗。
  • 采用Wilcoxon检验、卡方检验、Kaplan-Meier生存分析和Cox多因素风险分析进行组间比较。

主要发现

  • 微波消融组患者年龄更大(61岁[53-72] vs 59岁[51-68],p=0.01),年龄校正Charlson合并症指数更高(10[9-11] vs 8[7-9],p<0.0001)。
  • 微波消融组肿瘤位于后上段的比例更高(63.3% vs 53.2%,p=0.05)。
  • 两组在性别、BMI、CEA水平、肿瘤大小和围手术期化疗暴露方面相似。
  • 中位随访76个月,两组总生存无差异(5年总生存率51.5% vs 56.7%,p=0.6404)。
  • 两组无病生存无差异(5年无病生存率30.5% vs 36.2%,p=0.1042),肝切除组住院时间更长(4[3-6]天 vs 1[1-3]天,p<0.0001)。

临床怎么用

  • 对于小于3cm的单发结直肠癌肝转移,在合适患者中可考虑腹腔镜微波消融作为肝切除的替代方案。
  • 微波消融可能缩短住院时间,但需结合患者年龄、合并症和肿瘤位置综合评估。

局限性

  • 回顾性研究设计可能存在选择偏倚。
  • 微波消融组患者年龄更大、合并症更多、肿瘤位置更差,可能影响组间比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although traditionally reserved for unresectable lesions, recent studies have provided evidence that, in selected patients, microwave ablation (MWA) may provide similar oncologic outcomes compared with liver resection (LR). This study aimed to compare oncologic outcomes of patients with solitary small (less than 3 cm) colorectal cancer liver metastasis (CRLM) undergoing LR vs laparoscopic MWA. STUDY DESIGN: This retrospective study included patients with a solitary CRLM measuring less than 3 cm treated with LR or MWA in 3 centers over 25 years. Two groups were compared using the Wilcoxon test, chi-square test, Kaplan-Meier survival analysis, and Cox multivariate hazard analysis. Continuous data are presented as median (interquartile range p25 to 75). RESULTS: Among the patients who underwent either MWA (n = 158) or LR (n = 218) as the first line of local liver treatment, ablation patients were older (61 [53 to 72] vs 59 [51 to 68] years, p = 0.01), had a higher age-adjusted Charlson Comorbidity Index (10 [9 to 11] vs 8 [7 to 9], p < 0.0001) and a higher percentage of tumors located in posterosuperior segments (63.3% vs 53.2%, p = 0.05). The 2 groups were otherwise similar in terms of sex, BMI, CEA level, tumor size, and perioperative chemotherapy exposure. After a median follow-up of 76 months, there was no difference in overall survival (5-year overall survival 51.5% vs 56.7%, respectively, p = 0.6404) or disease-free survival (5-year disease-free survival 30.5% vs 36.2%, respectively, p = 0.1042) between the groups. Hospital stay was longer (4 [3 to 6] days vs 1 [1 to 3] days, p < 0.0001) in the LR group. CONCLUSIONS: In this multi-institutional study, laparoscopic MWA and resection had comparable outcomes in terms of disease-free survival and overall survival for less than 3 cm CRLM. Our findings support the noninferiority of ablation vs resection for the surgical treatment of small solitary CRLM in appropriate patients.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Akgun E, Butano V, Luo Q, et al. Laparoscopic Microwave Ablation vs Resection for Small Solitary Colorectal Liver Metastases: Multicenter Analysis of Long-Term Results. J Am Coll Surg. 2026. PMID: 40923629. doi:10.1097/XCS.0000000000001624

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。